The immunogenicity of colorectal cancers with high-degree microsatellite instability
Open Access
- 12 May 2005
- journal article
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 3 (1) , 26
- https://doi.org/10.1186/1477-7819-3-26
Abstract
Background High-degree microsatellite instability (MSI-H) is a feature of approximately 15% of sporadic colorectal cancers. Patients with MSI-H cancers have been reported to have a better prognosis than those with non-MSI-H cancers. The MSI-H subset is also characterised by a dense infiltrate of intra-epithelial lymphocytes and the hypothesis that the latter represents an efficacious immune response contributing to improved outcome is very attractive. Methods Data for this review were identified by searches of MEDLINE, PubMed, and cross references from relevant articles using the search terms 'microsatellite instability', 'colorectal cancer' and 'immunology', 'immune response' or 'immunogenicity'. Results A total of 38 articles were identified by the search criteria and a further 95 articles by cross-referencing. The relevance of the articles to be interviewed was established by hand searching. Out of a total of 133 articles identified, 47 articles were rejected due to lack of relevance. A total of 86 articles were included in the review, pertaining to microsatellite instability in colorectal cancer, and immune mechanisms in colorectal cancer. Conclusion It is suggested that this distinct group of colorectal cancers may have inherent immunogenic properties and that further elucidation of these may be invaluable to the development of successful immunotherapy.Keywords
This publication has 82 references indexed in Scilit:
- Systematic Review of Microsatellite Instability and Colorectal Cancer PrognosisJournal of Clinical Oncology, 2005
- Immune responses in cancerPharmacology & Therapeutics, 2003
- Evolution of colorectal cancer: Change of pace and change of directionJournal of Gastroenterology and Hepatology, 2002
- A TGFβRII frameshift-mutation-derived CTL epitope recognised by HLA-A2-restricted CD8 + T cellsCancer Immunology, Immunotherapy, 2001
- Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancerThe Lancet, 2000
- Replication error phenotype, clinicopathological variables, and patient outcome in Dukes' B stage II (T3,N0,M0) colorectal cancerGut, 2000
- Expression of Bcl-2 protein is decreased in colorectal adenocarcinomas with microsatellite instabilityOncogene, 1999
- Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinomaProceedings of the National Academy of Sciences, 1998
- Selection for β2-microglobulin mutation in mismatch repair-defective colorectal carcinomasCurrent Biology, 1996
- Human colorectal tumour infiltrating lymphocytes express activation markers and the CD45RO molecule, showing a primed population of lymphocytes in the tumour area.Gut, 1994